IS6143A - Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni - Google Patents

Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni

Info

Publication number
IS6143A
IS6143A IS6143A IS6143A IS6143A IS 6143 A IS6143 A IS 6143A IS 6143 A IS6143 A IS 6143A IS 6143 A IS6143 A IS 6143A IS 6143 A IS6143 A IS 6143A
Authority
IS
Iceland
Prior art keywords
virus
bind
monoclonal antibodies
peptide
virus peptide
Prior art date
Application number
IS6143A
Other languages
English (en)
Inventor
Sällberg Matti
Original Assignee
Tripep Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tripep Ab filed Critical Tripep Ab
Publication of IS6143A publication Critical patent/IS6143A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS6143A 1999-05-04 2001-11-01 Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni IS6143A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9901601A SE9901601D0 (sv) 1999-05-04 1999-05-04 Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
PCT/EP2000/003958 WO2000066621A1 (en) 1999-05-04 2000-05-03 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus

Publications (1)

Publication Number Publication Date
IS6143A true IS6143A (is) 2001-11-01

Family

ID=20415453

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6143A IS6143A (is) 1999-05-04 2001-11-01 Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni

Country Status (16)

Country Link
US (1) US20030022158A1 (is)
EP (1) EP1177210A1 (is)
JP (1) JP2003502285A (is)
KR (1) KR20020008172A (is)
CN (1) CN1352649A (is)
AU (1) AU4560800A (is)
CA (1) CA2370495A1 (is)
CZ (1) CZ20013638A3 (is)
HU (1) HUP0200869A2 (is)
IL (1) IL145848A0 (is)
IS (1) IS6143A (is)
NO (1) NO20015376L (is)
PL (1) PL352064A1 (is)
RU (1) RU2001127439A (is)
SE (1) SE9901601D0 (is)
WO (1) WO2000066621A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
WO2004067549A2 (de) * 2003-01-31 2004-08-12 Max-Delbrück-Centrum für Molekulare Medizin Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
AU2004209457A1 (en) 2003-02-06 2004-08-19 Tripep Ab Antigen/antibody or ligand/receptor glycosylated specificity exchangers
US20090269282A1 (en) * 2006-10-05 2009-10-29 Ellis John A Methods for treating, preventing and diagnosing procine ttv infection
BRPI0920248A2 (pt) * 2008-10-16 2016-01-05 Pfizer isolados e composicoes do virus torque teno(ttv)
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
MX2012004448A (es) * 2009-10-16 2012-05-08 Pfizer Clones infecciosos de torque teno virus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1010759B1 (en) * 1997-07-25 2007-03-28 Tamura, Ryoji Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
WO1999058638A2 (en) * 1998-05-13 1999-11-18 Innogenetics N.V. Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
JP2000135087A (ja) * 1998-10-29 2000-05-16 Srl Inc 抗ｔｔウイルス抗体測定用ペプチド及びそれを用いたｔｔウイルスの血清型分類方法

Also Published As

Publication number Publication date
HUP0200869A2 (en) 2002-08-28
AU4560800A (en) 2000-11-17
CA2370495A1 (en) 2000-11-09
JP2003502285A (ja) 2003-01-21
SE9901601D0 (sv) 1999-05-04
US20030022158A1 (en) 2003-01-30
EP1177210A1 (en) 2002-02-06
WO2000066621A1 (en) 2000-11-09
CZ20013638A3 (cs) 2002-03-13
CN1352649A (zh) 2002-06-05
KR20020008172A (ko) 2002-01-29
PL352064A1 (en) 2003-07-28
RU2001127439A (ru) 2004-02-27
NO20015376L (no) 2001-12-06
NO20015376D0 (no) 2001-11-02
IL145848A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
GB0029360D0 (en) Humanised antibodies and uses thereof
IS2620B (is) Mennskgerð mótefni sem greina beta-amýlóíðpeptíð
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
IL158643A (en) Anti-hmg monoclonal antibodies and compositions containing the same
HUP0204074A3 (en) Humanized antibodies that sequester abetha peptide
CY2012003I2 (el) Αντισωματα που συνδεονται ανοσοειδικως προς blys
EE200300179A (et) Humaniseeritud LT-ß-R-i vastased antikehad
AU5081401A (en) Anti-tissue factor antibodies with enhanced anticoagulant potency
HK1086598A1 (en) Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
ITRM990803A0 (it) Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
EE200300569A (et) CD44v6-spetsiifilised antikehad
IS6143A (is) Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni
HUP0103152A3 (en) Monoclonal antibodies directed against the g3bp protein, and uses
EP1218413A4 (en) IRREVERSIBLE BINDING ANTIBODY MANIPULATIONS
TR199800604A3 (tr) Anti-fas antikorlari.
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
NO20011006L (no) Höy-affinitets antistoffer
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
HUP0202270A2 (en) Antitumor antibodies, proteins, and uses thereof
FI20011055A0 (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
EP1455822A4 (en) LYOPHILIZED MONOCLONAL ANTIBODY COMPOSITIONS
ITPD20000192A0 (it) Anticorpi policlonali
TR199902750A3 (tr) Anti-p53 monoklonal antikorlar ve kullanimlari.